Loading Events

Past Events › Grant

Events Search and Views Navigation

Event Views Navigation

May 2022

Pediatric Epilepsy Research Foundation (PERF) Scientific Grant

May 15

Sponsor: Pediatric Epilepsy Research Foundation
Due Date: May 15, 2022
Award: Supports clinical or basic science research by a child neurologist or developmental pediatrician early in his/her academic career. The selected investigator will receive a $100,000 grant of $50,000 per year for two years. The PERF Grant is supported fully by PERF.

Find out more »

Cycle 2: Alzheimer’s Drug Discovery Foundation

May 20

CYCLE 2 Deadlines

  • Letter of Intent: May 20, 2022
  • Full Proposal: July 22, 2022
     

Drug Discovery Program
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project depending on the stage of research and must be justified based on the scientific work plan. In some cases, multi-year proposals can be considered.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

Cycle 2: Biomarkers Development

May 20

Sponsor: Alzheimer’s Drug Discovery Foundation

Deadlines:
Letter of Intent: May 20, 2022
Invited Full Proposal: July 22, 2022

Award: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Award Amount:
Up to $600,000 based on stage and scope of research.

Find out more »

NEXT GEN PREGNANCY INITIATIVE

May 20

Sponsor: Burroughs Wellcome Fund

Deadline: May 20, 2022 by 4:00pm EST

Award: “We seek to expand the scope of this award mechanism to capture these and other pregnancy outcomes as we believe they will be mutually informative and accelerate discovery. Each award will continue to provide up to $500,000 over a four-year period ($125,000 per year).

The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach healthy and adverse pregnancy outcomes using creative basic and translation science methods. The formation of new connections between reproductive scientists and investigators who are involved in other areas is particularly encouraged.”

Find out more »

Cycle 2: The Midlife in the United States Study (U19)

May 25

Sponsor: National Institutes of Health

Due Date: May 25, 2022

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Find out more »

Cycle 2: NIA Program Project Applications (P01)

May 25

Sponsor: National Institutes of Health
Application Due Date: May 25, 2022 by 5:00 pm local time of applicant organization
Award: The National Institute on Aging (NIA) invites the submission of investigator-initiated research program project (P01) applications addressing scientific areas relevant to NIA’s mission. Each application submitted to this Funding Opportunity Announcement (FOA) must include at least three related research projects that share a common central theme, focus, and overall objective, in addition to an administrative core to lead the project. Revision applications should include expansion of an existing, or proposal of a new, project or projects within the context and theme of the parent P01 award. Revision applications may not request support beyond the end date of the parent P01 award, but may propose to expand existing cores, or propose new cores, to support the expansion or creation of new projects. The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Find out more »

Cycle 2: Ruth L. Kirschstein National Research Service Award (T series)

May 25

Sponsor: National Institutes of Health
Due Date: May 25, 2022
Award: The award described in this announcement is designed to provide training opportunities in dental, oral and craniofacial research by supporting integrated but flexible institutional programs. The awards are comprehensive training grants to fund pre-doctoral, post-doctoral and short-term trainees.

Find out more »

June 2022

Foundation for Physical Therapy

June 1

DUE JUNE1, 2022
Foundation Research Grant
The Foundation for Physical Therapy Research (FPTR) is the only national nonprofit solely dedicated to funding physical therapy research. Since 1979, FPTR has awarded more than $20 million in research grants, scholarships, and fellowships to the most promising physical therapist researchers. In the current grant funding cycle, FPTR will award up to a half million in research grants. Please note important dates, guidelines, and instructions below.
This grant will provide $40,000 for either one or two year projects.

Snyder Research Grant
One $40,000 SRG is to be awarded to support relevant clinical research projects aimed to investigate: a) those services delivered by physical therapists; and b) the development of new interventions that offer reasonable assurance that they will be clinically relevant and therapeutically effective.

Find out more »

Cycle 2: PCORI Research Awards

June 1

Sponsor: PCORI

Deadlines:

LOI: June 1, 2022 at 5 PM ET
APPLICATION DEADLINE: August 31, 2022 at 5 PM ET

Awards:

Communication and Dissemination Research
“Under the Communication and Dissemination Research priority area, PCORI invites applications that support approaches to comparing communication strategies, dissemination strategies, or implementation strategies for overcoming barriers to adoption, adaptation, integration into routine clinical care, and sustainability of evidence-based interventions. Additionally, PCORI is interested in comparing strategies for stopping or halting practices that have not been proven to be effective and are possibly harmful (also known as de-implementation).

PCORI has increased the maximum direct cost project budget for proposed studies in this priority area to be up to $5 million for each award, with a maximum performance period of five years. Please note, proposed applications may not exceed $5 million in direct costs if germane to the Communication and Dissemination Research priority area.”

Phased Large Awards for Comparative Effectiveness Research: $22 million (Feasibility phase: $2 million; Full-scale study phase: $20 million)

Comparative Effectiveness of Multimodal Interventions to Prevent Osteoporotic Fractures: Up to $10 million

Comparative Effectiveness of Novel Pharmacologic and Evidence-Based Nonpharmacologic Treatments for Migraine Prevention: Up to $10 million

Healthy Aging: Optimizing Physical and Mental Functioning Across the Aging Continuum: Up to $5 million

Broad PCORI Funding Announcements: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Healthcare Systems: up to $3 million (Small) – up to $5 million (Large) — Communication & Dissemination Research: up to $2 million

Improving Methods for Conducting Patient-Centered Outcomes Research: $750,000

You can register here Virtual Applicant Town Halls for these Funding Announcements

Find out more »

Postdoctorial Fellowships in Basic, Pre-Clinical, and Translational Stem Cell Studies

June 1

Sponsor: The New York Stem Cell Foundation

Deadline: June 1, 2022

Award: NYSCF encourages applications focused on basic, pre-clinical, and/or translational studies in stem cell research including technology development, disease modeling, drug discovery, and therapeutics. Applicants studying induced pluripotent stem cells, human embryonic stem cells, and differentiated cells derived from them are particularly encouraged to apply.

The fellowship provides an annual stipend of $58,500 (plus $2,500 for computer and travel expenses). Fellowships will be awarded for up to 2 years with the possibility of a 3rd year of funding pending satisfactory progress. The fellowship does not provide institutional overhead.

Find out more »

Cycle 2: NIH Cycles R01 and U01

June 5

DEADLINE: JUNE 5, 2022

NINDS Exploratory Clinical Trials (U01)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website.
NINDS Efficacy Clinical Trials (U01)
he purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for  investigator-initiated clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS) to establish the efficacy (or compare the effectiveness) of treatment interventions. Budgets must reflect the actual needs; maximum request cannot exceed 5 years.
Promoting Research in Basic Neuroscience (R01)
The goal of this Funding Opportunity Announcement (FOA) is to stimulate research addressing fundamental questions in basic neuroscience. Budgets must reflect the actual needs; maximum request cannot exceed 5 years.
Prevention Research in Mid-Life Adults (R01)
This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years. Budgets must reflect the actual needs; maximum request cannot exceed 5 years.
Pregnancy in Woman with Disabilities (R01)
Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Application budgets are not limited but need to reflect the actual needs of the proposed project.

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01): The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimer’s disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. There is particular interest in interventions that can be implemented in community settings by the affected individual, informal caregivers, or others in the community. Research to inform the development of such interventions is also of interest, as well as research examining underlying mechanisms and biomarkers associated with response to interventions. It is anticipated that the results of this research will help affected individuals maintain independence and quality of life, improve their ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), and additionally help to reduce stress, burden, and other poor outcomes in their caregivers.

High Throughput Screening (HTS) to Discover Chemical Probes (R01): Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatments relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease targets and processes.

Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01): Budgets for direct costs of up to $499,999 per year may be requested. Project period may not exceed 5 years. This funding opportunity announcement (FOA) encourages applications from institutions/ organizations addressing preclinical research in model organisms of neurodevelopmental disorders. Applications submitted to this FOA should propose to develop, validate, and/or calibrate outcome measures, surrogate markers, and biomarkers in model organisms that can inform and effectively translate to human clinical trials for individuals with intellectual and developmental disabilities (IDD).

 

Find out more »

Cycle 2: Career Transition Award for NINDS Intramural Clinician-Scientists (K22)

June 12

Sponsor: National Institutes of Health
Due Date: June 12, 2022
Award: Award budgets are composed of salary and other program related expenses. Total project period may not exceed 5 years.

Find out more »

ABTA Basic Research Fellowship Program 

June 14

Sponsor: American Brain Tumor Association
Letter of Intent: February 23, 2022;
Full Application: March 30, 2022
Award: Basic Research Fellowships are two-year, $100,000 mentored grants supporting postdoctoral fellows who are conducting laboratory or field-based research projects that focus on brain tumors.

Find out more »

ADDF-Harrington Scholar Program

June 14

Sponsor: Alzheimer’s Drug Discovery Foundation
LOI due date:  July 18th, 2022, 5:00 PM EDT
Full Application due date: October 24, 2022, 5:00 PM EDT
Award: Proposals should show potential to advance discovery into meaningful therapeutics designed to treat, prevent, or slow Alzheimer’s disease or related dementias; average award is up to $600,000 over 2 years

Find out more »

Dr. Ralph and Marian Falk Medical Research Trust – Transformational Awards Program

June 16

Sponsor: The Medical Foundation

Deadline: June 16, 2022 @ 2:00 P.M., EDT

Award: The Transformational Research Award provides two to three years of additional research funding up to $1M for successful projects funded by Catalyst Awards. The Transformational Award will continue to support successful Catalyst Award Recipients’ work, helping help them move a healthcare innovation toward the next step in commercial development, tackling critical scientific and therapeutic roadblocks, and thereby opening new avenues for treating and curing disease. Transformational Awards will be granted based on both scientific merit and having successfully attained the proposed milestones and benchmarks of the Catalyst Award, thus demonstrating its successful execution within the proposed budget and projected timeframe.

Find out more »

Cycle 1: Ruth L. Kirschstein National Research Service Awards (T Series)

June 17 @ 8:00 am - 5:00 pm

Sponsor: NIH
Deadline: 1/25/2022
Award: The National Institutes of Health (NIH) awards Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nation’s biomedical, behavioral and clinical research agenda. The primary objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages applications for predoctoral NRSA T32s to provide research training in systems biology of developmental biology and/or structural birth defects research.

Find out more »

BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3)

June 20
|Recurring Event (See all)

One event on September 21, 2020 at 12:00 am

Sponsor: National Institutes of Health

Deadlines: February 18, 2022 & June 20, 2022 & October 18, 2022

Award: The NIH anticipates providing $10M per year to fund an estimated 5 to 7 awards. Application budgets are not limited but need to reflect the actual needs of the proposed project. Budgets should rarely exceed $2M. The total duration may not exceed 5 years.

Find out more »

Cycle 2: Dissemination and Implementation of PCORI-Funded Patient-Centered Outcomes Research Results and Products in Real-World Settings

June 21

Sponsor: PCORI

Deadline: June 21, 2022

Award: The intent of this limited PFA is to move evidence developed with PCORI research funding toward practical use in improving health care and health outcomes. PCORI will fund projects that aim to implement patient-centered clinical comparative effectiveness research (CER) results obtained from PCORI-funded studies in real-world practice settings, and, in selected cases, projects that focus on the dissemination of these findings.

Find out more »

Smith Family Awards Program for Excellence in Biomedical Research

June 22

Sponsor: The Medical Foundation

Deadline: June 22, 2022 at 12 PM ET

Award: Three year awards in the amount of $300,000 ($100,000 per year inclusive of 5% overhead) target new faculty who are within two and a half years of their first independent appointment by the start of funding on December 1st. Applicants, nominated by their institutions, must be full-time faculty at nonprofit academic, medical or research institutions in Massachusetts, at Brown University or at Yale University.

Find out more »

Cycle 2: NIH Academic Research Enhancement Award (R15)

June 25

Sponsor: National Institutes of Health
Due Date: June 25, 2022 by 5 pm local time of applicant organization
Award: R15s support individual research projects in the biomedical and behavioral sciences conducted by faculty located in undergraduate-focused institutions, health professional schools, and graduate schools that have not been major recipients of NIH research grant funds.

Find out more »
+ Export Events